Evidence map›Paper›PMID 34260977›Full record

ReviewRespiratory medicine2021

Low dose lung radiotherapy for COVID-19 pneumonia: A potential treatment.

Sweety Gupta, Rachit Ahuja, Nidhi Sharma, Pragya Singh, Swati Verma, Manoj Gupta

Open access · bronzeAbstract readReview
In one paragraph

Review in Respiratory medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. The immunology and immunotherapy for COVID-19.Expert reviews in molecular medicine · 2021
    Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Sweety GuptaDepartment of Radiation Oncology, AIIMS, Rishikesh, India. Electronic address: sweety.rt@aiimsrishikesh.edu.in.
Rachit AhujaDepartment of Radiation Oncology, AIIMS, Rishikesh, India.
Nidhi SharmaDepartment of Radiation Oncology, AIIMS, Rishikesh, India.
Pragya SinghDepartment of Radiation Oncology, AIIMS, Rishikesh, India.
Swati VermaDepartment of Radiation Oncology, AIIMS, Rishikesh, India.
Manoj GuptaDepartment of Radiation Oncology, AIIMS, Rishikesh, India.
All India Institute of Medical Sciences Raipur · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The covid-19 pandemic has been affecting many countries across the world and lost precious lives. Most patients suffer from respiratory disease which progresses to the severe acute respiratory syndrome, termed as SARS-CoV-2 pneumonia. A systemic inflammatory response occurs in SARS-CoV-2 pneumonia severely ill patients, The inflammation process if uncontrolled has a detrimental effect, and the release of cytokines play an important role leading to lung fibrosis. Radiation therapy used in low doses has an anti-inflammatory and immunomodulatory effect. Its low cost, wider availability, and decreased risk of acute side effects can reduce the burden on the health care system.

Indexed as

COVID-19CytokinesDisease ProgressionHumansInflammationInflammation MediatorsMacrophagesPulmonary FibrosisRadiotherapyRadiotherapy DosageSARS-CoV-2Severe Acute Respiratory SyndromeSeverity of Illness IndexCytokinesInflammation MediatorsCOVID-19 pneumoniaInflammationLow dose radiation therapyMacrophages

Identifiers

PMID34260977
PMCPMC8261133
OpenAlexW3179072354

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.